DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Kim Y, Lee SJ, Lee JY. et al.
Clinical trial of nintedanib in patients with recurrent or metastatic salivary
gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer
Study Group HN14-01).
Cancer 2017;
123: 1958-1964
We do not assume any responsibility for the contents of the web pages of other providers.